The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial
- PMID: 30304644
- PMCID: PMC6376602
- DOI: 10.1177/2047487318806358
The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial
Erratum in
-
CORRIGENDUM: The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial.Eur J Prev Cardiol. 2020 Dec;27(18):NP17. doi: 10.1177/2047487320974256. Epub 2020 Nov 9. Eur J Prev Cardiol. 2020. PMID: 33167687 Free PMC article. No abstract available.
Abstract
Background: Cardiac rehabilitation improves health-related quality of life (HRQoL) and reduces hospitalizations in patients with heart failure, but international uptake of cardiac rehabilitation for heart failure remains low.
Design and methods: The aim of this multicentre randomized trial was to compare the REACH-HF (Rehabilitation EnAblement in CHronicHeart Failure) intervention, a facilitated self-care and home-based cardiac rehabilitation programme to usual care for adults with heart failure with reduced ejection fraction (HFrEF). The study primary hypothesis was that the addition of the REACH-HF intervention to usual care would improve disease-specific HRQoL (Minnesota Living with Heart Failure questionnaire (MLHFQ)) at 12 months compared with usual care alone.
Results: The study recruited 216 participants, predominantly men (78%), with an average age of 70 years and mean left ventricular ejection fraction of 34%. Overall, 185 (86%) participants provided data for the primary outcome. At 12 months, there was a significant and clinically meaningful between-group difference in the MLHFQ score of -5.7 points (95% confidence interval -10.6 to -0.7) in favour of the REACH-HF intervention group ( p = 0.025). With the exception of patient self-care ( p < 0.001) there was no significant difference in other secondary outcomes, including clinical events ( p > 0.05) at follow-up compared with usual care. The mean cost of the REACH-HF intervention was £418 per participant.
Conclusions: The novel REACH-HF home-based facilitated intervention for HFrEF was clinically superior in disease-specific HRQoL at 12 months and offers an affordable alternative to traditional centre-based programmes to address current low cardiac rehabilitation uptake rates for heart failure.
Keywords: Cardiac rehabilitation; health-related quality of life; heart failure; home-based; randomized controlled trial; self-management.
Figures
Comment in
-
Home-based rehabilitation interventions aimed at congestive heart failure: Are we there yet?Eur J Prev Cardiol. 2019 Feb;26(3):259-261. doi: 10.1177/2047487318816783. Epub 2018 Nov 30. Eur J Prev Cardiol. 2019. PMID: 30501373 No abstract available.
-
Home-based rehabilitation for heart failure: we need to act now.Eur J Prev Cardiol. 2019 Aug;26(12):1343-1344. doi: 10.1177/2047487319836515. Epub 2019 Mar 16. Eur J Prev Cardiol. 2019. PMID: 30880438 No abstract available.
References
-
- Braunwald E. The war against heart failure: The Lancet lecture. Lancet 2015; 385: 812–824. - PubMed
-
- Calvert MJ, Freemantle N, Cleland JGF. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail 2005; 7: 243–251. - PubMed
-
- Lewis EF, Johnson PA, Johnson W, et al. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001; 20: 1016–1024. - PubMed
-
- Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147–e239. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
